Ngā hua rapu - C. David Mazer
- E whakaatu ana i te 1 - 20 hua o te 69
- Haere ki te Whārangi Whai Ake
-
1
Antiplatelet Drugs mā Richard Hall, C. David Mazer
I whakaputaina 2011Revisão -
2
-
3
-
4
-
5
Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies mā Brian Hutton, L. Joseph, Dean Fergusson, C. David Mazer, Shelley Shapiro, Alan Tinmouth
I whakaputaina 2012Revisão -
6
-
7
-
8
-
9
-
10
Intracranial Hemorrhage During Dual Antiplatelet Therapy mā Andrew C.T. Ha, Deepak L. Bhatt, James T. Rutka, S. Claiborne Johnston, C. David Mazer, Subodh Verma
I whakaputaina 2021Revisão -
11
-
12
Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG... mā Subodh Verma, C. David Mazer, David Fitchett, Silvio E. Inzucchi, Egon Pfarr, Jyothis T. George, Bernard Zinman
I whakaputaina 2018Artigo -
13
-
14
-
15
-
16
Selective β1-Antagonism with Bisoprolol Is Associated with Fewer Postoperative Strokes than Atenolol or Metoprolol mā Catherine Ashes, Saul Judelman, Duminda N. Wijeysundera, Gordon Tait, C. David Mazer, Gregory M. T. Hare, W. Scott Beattie
I whakaputaina 2013Artigo -
17
Anemia and Cerebral Outcomes: Many Questions, Fewer Answers mā Gregory M. T. Hare, Albert K.Y. Tsui, Anya T. McLaren, Tenille E. Ragoonanan, Julie Yu, C. David Mazer
I whakaputaina 2008Revisão -
18
-
19
-
20
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Surgery
Cardiology
Intensive care medicine
Anesthesia
Cardiac surgery
Pathology
Endocrinology
Myocardial infarction
Perioperative
Randomized controlled trial
Alternative medicine
Placebo
Blood transfusion
Blood management
Confidence interval
Diabetes mellitus
Anemia
Empagliflozin
Engineering
Heart failure
Mechanical engineering
Type 2 diabetes
Acute kidney injury
Chemistry
Emergency medicine
Meta-analysis
Stroke (engine)
Blood pressure